Catalyst Wire Dossier Catalyst Wire Dossier

Sublingual 5-MeO-DMT

5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) · Biomind Labs Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sublingual 5-MeO-DMT, covering 2025-04-09 to 2025-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Sublingual 5-MeO-DMT for Reducing Anxiety and Depression in MCI [Phase 1, Phase 2]

See pricing